Celiac Disease - Pipeline Assessment and Market Forecasts to 2019

Dec. 1, 2011 - PRLog -- GlobalData estimates that the global celiac disease therapeutics market will worth $512.3m in 2017. This market is expected to grow at a Compound Annual Growth Rate (CAGR) of 13.9% to reach $664.4m by 2019. This high growth forecast is primarily attributed to the increased uptake of the pipeline products and increase in diagnosis rates.

Celiac disease is a widespread, lifelong disorder for which gluten-free diet is the only accepted form of therapy. Although treatment with gluten-free diet is safe and effective for the vast majority of the patients it is relatively expensive, limits nutritional variety, often restricts social activities and difficult to maintain. Therefore, there is a significant unmet need for non-dietary therapies to treat this condition.

The celiac disease therapeutics market has huge potential for new drugs or therapies due to a large patient pool and lack of pharmacological therapies. No drug has been approved till date for the treatment of celiac disease. Therefore, the market provides an opportunity for new entrants if they have a convenient route of administration/schedule, an enhanced long term efficacy and safety profile and cost effectiveness.

For Sample Pages, please click or add the below link to your browser:
http://www.globaldata.com/reportstore/RequestSamplePages....

GlobalData found the celiac disease therapeutics pipeline to be weak. It consists of 13 first-in-class molecules in different stages of development. There is no molecule in the Phase III stage of clinical development. Pipeline has two molecules in Phase II, ALV003 and larazotide acetate (AT1001). These molecules may enter into the market late into the forecast period. These molecules, if gets approval will drive the growth of celiac disease therapeutics market during the forecast period.

GlobalData, the industry analysis specialist, has released its new report, “Celiac disease Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global celiac disease therapeutics market. The report identifies the key trends shaping and driving the global celiac disease therapeutics market. Most importantly, the report provides valuable insights on the pipeline products within the global celiac disease therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

For further details, please click or add the below link to your browser:
http://www.globaldata.com/reportstore/Report.aspx?ID=Celi...

Visit our report store: http://www.globaldata.com/reportstore


For more details contact:
pressreleases@globaldata.com
           
North America:    +1 646 395 5477
Europe:        +44 207 753 4299
           +44 1204 543 533
Asia Pacific:       +91 40 6616 6782

# # #

GlobalData is a global market intelligence services company providing information research and analysis products and services.